Table 1

Baseline Characteristics Stratified by Tertiles of GLS

TotalGLS
<−13.0%
GLS
−8.7 to −13.0%
GLS
>−8.7%
p Value
Age, yrs59.8 ± 15.756.3 ± 16.660.2 ± 14.762.8 ± 15.1<0.001
Male65.366.762.566.90.427
BMI, kg/m228.9 ± 8.628.2 ± 6.528.9 ± 6.629.4 ± 11.60.199
Diabetes30.624.930.236.70.004
Hyperlipidemia54.750.254.958.80.078
Smoking14.812.913.118.30.085
Hypertension66.761.166.872.20.010
History of MI28.926.125.435.10.010
Ischemic CM49.943.843.762.1<0.001
Nonischemic dilated CM50.156.256.337.9<0.001
Aspirin63.257.160.372.30.001
Statin55.953.556.457.80.544
ACE Inhibitor or ARB66.257.070.570.00.001
Beta-blocker49.640.854.353.40.001
Diuretic44.631.848.853.00.001
Heart rate, beats/min76.5 ± 16.570.4 ± 13.877.5 ± 16.381.3 ± 17.4<0.001
Systolic BP, mm Hg123.1 ± 20.7124.9 ± 20.8124.7 ± 20.6119.9 ± 20.30.010
Diastolic BP, mm Hg72.7 ± 13.572.0 ± 12.973.7 ± 13.372.4 ± 14.30.371
LVEDV index, ml/m2117.9 ± 54.6102.3 ± 40.6116.7 ± 55.9134.5 ± 60.3<0.001
LVESV index, ml/m267.1 ± 44.248.7 ± 26.867.1 ± 42.285.2 ± 51.9<0.001
LV mass index, g/m2113.7 ± 26.4110.6 ± 27.0112.9 ± 52.1117.5 ± 45.10.850
LGE present62.151.759.574.9<0.001
LGE extent, %8.4 ± 10.16.3 ± 8.47.4 ± 9.311.6 ± 11.6<0.001
LVEF, %33.7 ± 10.040.3 ± 6.834.0 ± 8.626.8 ± 9.3<0.001

Values are mean ± SD or %.

ACE = angiotensin converting enzyme; ARB = angiotensin receptor blocker; BMI = body mass index; CM = cardiomyopathy; GLS = global longitudinal strain; LGE = late gadolinium enhancement; LVEDV = left ventricular end diastolic volume index; LVEF = left ventricular ejection fraction; LVESV = left ventricular end systolic volume index; MI = myocardial infarction.